Keeler Thomas Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.42M Buy
18,144
+1,489
+9% +$102K 0.5% 66
2026
Q1
$1.08M Sell
16,655
-2,524
-13% -$178K 0.46% 67
2025
Q4
$1.29M Sell
19,179
-18
-0.1% -$1.21K 0.62% 53
2025
Q3
$1.41M Buy
19,197
+292
+2% +$19.4K 0.57% 55
2025
Q2
$983K Buy
+18,905
New +$1.08M 0.42% 84

Other funds holding HALO

Keeler Thomas Management's HALO Position: Q2 2026 in Review

Keeler Thomas Management increased its Halozyme (HALO) stake by 8.9% in Q2 2026, buying an estimated $102K and bringing the position to 18,144 shares worth $1.42M. The position accounts for 0.5% of the portfolio, ranked #66.

Keeler Thomas Management first reported a position in HALO in Q2 2025 and has held it in 5 quarters since. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Keeler Thomas Management held 18,144 shares of Halozyme worth $1.42M as of Q2 2026.
  • Keeler Thomas Management bought 1,489 Halozyme shares in Q2 2026, an estimated $102K.
  • Halozyme made up 0.5% of Keeler Thomas Management's portfolio in Q2 2026, its #66 holding.
  • Keeler Thomas Management first reported a position in Halozyme in Q2 2025 and has held it in 5 quarters since.
  • 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Keeler Thomas Management's 13F filing for Q2 2026, filed 30 Jul 2026.